Fenfluramine Hydrochloride Global Patent Coverage & Expiry Overview

Track protection status across key markets to assess launch feasibility.

Start your free 7-Day Trial! Book a demo to explore our global patent data.

It is formulated by 1 pharmaceutical company such as UCB INC. It is marketed under 1 brand name, including FINTEPLA. Available in 1 different strength, such as EQ 2.2MG BASE/ML, and administered through 1 route including SOLUTION;ORAL.

Strategic Dashboard

info

insightsStrategic Insights

Sourcing & Feasibility

check_circle API availability: autorenew Loading API feasibility...

groups Licensing: 1 potential partners

calendar_todayUS Launch window: autorenew Loading launch window...

timeline Key Patent Barrier & Expiry Timeline

autorenew Loading patent barriers...

factoryGeneric Manufacturer Snapshot

autorenew Loading manufacturers...

gavelRisk & Opportunity Summary

dangerous Risk: autorenew Loading risk analysis...
watch_later Watch: autorenew Loading watch analysis...
rocket_launch Opportunity: autorenew Loading opportunity analysis...
flag
gavel
calendar_today
calendar_today

Access Global Patent Data

Stay ahead with worldwide patent expiry and latest updates.

✓ Comprehensive global patent expiry timelines
✓ Full patent family details and status updates
Unlock Global Patents

Orange Book Drug Approval Timeline

FDA approval history for this ingredient

NDA (New Drug Application) ANDA (Generic Application)

Access Global Exclusivity and Patent Expiry Extensions

Stay ahead with worldwide patent expiry insights, exclusivity data, and latest updates.

✓ Comprehensive global patent expiry timelines
✓ Full patent family details and status updates
✓ Latest exclusivity data and extensions
Unlock Global Access

US Orange Book Patents Expiration Timeline

Key expiration dates for US patents covering this ingredient

View Global Patents Expiration Timeline

Stay ahead with worldwide patent expiry insights, market data, and research updates.

✓ Comprehensive global patent expiry timelines
✓ Full patent family details and status updates
Unlock Global Patent Timeline

Orange Book Drug Strengths

Latest drug strengths approved by FDA

Strength Route of Administration Companies Latest Approval Date

Orange Book Patents

Patents approved by the FDA for the ingredient

Patent Number Publication Date Legal Status Patent Expiry Date
{"application_id":"36068","ingredient":"FENFLURAMINE HYDROCHLORIDE","trade_name":"FINTEPLA","family_id":"be0d9b0054e64f57b2e7","publication_number":"US9610260B2","cleaned_patent_number":"9610260","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2033-11-03","publication_date":"2017-04-04","legal_status":"Granted"} US9610260B2 04 Apr, 2017 Granted 03 Nov, 2033
{"application_id":"31608","ingredient":"FENFLURAMINE HYDROCHLORIDE","trade_name":"FINTEPLA","family_id":"be0d9b0054e64f57b2e7","publication_number":"US20220160727A1","cleaned_patent_number":"12097206","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2033-11-03","publication_date":"2022-05-26","legal_status":"Pending"} US12097206B2 26 May, 2022 Pending 03 Nov, 2033
{"application_id":"36065","ingredient":"FENFLURAMINE HYDROCHLORIDE","trade_name":"FINTEPLA","family_id":"be0d9b0054e64f57b2e7","publication_number":"US9549909B2","cleaned_patent_number":"9549909","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2033-11-03","publication_date":"2017-01-24","legal_status":"Granted"} US9549909B2 24 Jan, 2017 Granted 03 Nov, 2033
{"application_id":"36066","ingredient":"FENFLURAMINE HYDROCHLORIDE","trade_name":"FINTEPLA","family_id":"be0d9b0054e64f57b2e7","publication_number":"US9603814B2","cleaned_patent_number":"9603814","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2033-11-03","publication_date":"2017-03-28","legal_status":"Granted"} US9603814B2 28 Mar, 2017 Granted 03 Nov, 2033
{"application_id":"36067","ingredient":"FENFLURAMINE HYDROCHLORIDE","trade_name":"FINTEPLA","family_id":"be0d9b0054e64f57b2e7","publication_number":"US9603815B2","cleaned_patent_number":"9603815","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2033-11-03","publication_date":"2017-03-28","legal_status":"Granted"} US9603815B2 28 Mar, 2017 Granted 03 Nov, 2033
{"application_id":"36070","ingredient":"FENFLURAMINE HYDROCHLORIDE","trade_name":"FINTEPLA","family_id":"be0d9b0054e64f57b2e7","publication_number":"US10478442B2","cleaned_patent_number":"10478442","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2033-11-03","publication_date":"2019-11-19","legal_status":"Granted"} US10478442B2 19 Nov, 2019 Granted 03 Nov, 2033
{"application_id":"36069","ingredient":"FENFLURAMINE HYDROCHLORIDE","trade_name":"FINTEPLA","family_id":"be0d9b0054e64f57b2e7","publication_number":"US10478441B2","cleaned_patent_number":"10478441","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2033-11-03","publication_date":"2019-11-19","legal_status":"Granted"} US10478441B2 19 Nov, 2019 Granted 03 Nov, 2033
{"application_id":"8930","ingredient":"FENFLURAMINE HYDROCHLORIDE","trade_name":"FINTEPLA","family_id":"7345a9e43194473b9f46","publication_number":"US10947183B2","cleaned_patent_number":"10947183","drug_product_flag":"-, Y","drug_substance_flag":"-, Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2037-06-20","publication_date":"2021-03-16","legal_status":"Granted"} US10947183B2 16 Mar, 2021 Granted 20 Jun, 2037
{"application_id":"35689","ingredient":"FENFLURAMINE HYDROCHLORIDE","trade_name":"FINTEPLA","family_id":"7effa4a00299415889c7","publication_number":"US11759440B2","cleaned_patent_number":"11759440","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2038-02-02","publication_date":"2023-09-19","legal_status":"Granted"} US11759440B2 19 Sep, 2023 Granted 02 Feb, 2038
{"application_id":"8974","ingredient":"FENFLURAMINE HYDROCHLORIDE","trade_name":"FINTEPLA","family_id":"7effa4a00299415889c7","publication_number":"US10603290B2","cleaned_patent_number":"10603290","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2038-02-02","publication_date":"2020-03-31","legal_status":"Granted"} US10603290B2 31 Mar, 2020 Granted 02 Feb, 2038
{"application_id":"8985","ingredient":"FENFLURAMINE HYDROCHLORIDE","trade_name":"FINTEPLA","family_id":"7effa4a00299415889c7","publication_number":"US11040018B2","cleaned_patent_number":"11040018","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2038-02-02","publication_date":"2021-06-22","legal_status":"Granted"} US11040018B2 22 Jun, 2021 Granted 02 Feb, 2038
{"application_id":"31312","ingredient":"FENFLURAMINE HYDROCHLORIDE","trade_name":"FINTEPLA","family_id":"7effa4a00299415889c7","publication_number":"US11406606B2","cleaned_patent_number":"11406606","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2038-02-02","publication_date":"2022-08-09","legal_status":"Granted"} US11406606B2 09 Aug, 2022 Granted 02 Feb, 2038
{"application_id":"35686","ingredient":"FENFLURAMINE HYDROCHLORIDE","trade_name":"FINTEPLA","family_id":"7effa4a00299415889c7","publication_number":"US11786487B2","cleaned_patent_number":"11786487","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2038-02-02","publication_date":"2023-10-17","legal_status":"Granted"} US11786487B2 17 Oct, 2023 Granted 02 Feb, 2038
{"application_id":"18144","ingredient":"FENFLURAMINE HYDROCHLORIDE","trade_name":"FINTEPLA","family_id":"f77602540b3b4cdfb708","publication_number":"US10452815B2","cleaned_patent_number":"10452815","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2038-12-29","publication_date":"2019-10-22","legal_status":"Granted"} US10452815B2 22 Oct, 2019 Granted 29 Dec, 2038

Recent Clinical Trials

Latest clinical trials and research studies for this ingredient

NCT ID Title Status Phase Conditions Start Date Completion Date

API Suppliers/Manufacturer (Branded/Generic companies)

Manufacturing Locations

View Complete Supplier List

Unlock access to all suppliers of Fenfluramine Hydrochloride

✓ Access a comprehensive list of global suppliers
✓ Get information on each supplier
Unlock Suppliers

Note: Patent expirations and exclusivity timelines are dynamic and may shift based on litigation, regulatory extensions, and maintenance filings. Regular monitoring is advised.

GreyB © 2025 Elixir. All rights reserved.